Amblyopia, a prevalent visual impairment, not only affects the vision of individuals but also has a profound impact on their quality of life. However, traditional treatments for amblyopia often suffer from issues such as prolonged therapy duration and inconsistent effectiveness. Therefore, the development of an efficient, safe, and convenient amblyopia treatment device has become an urgent priority.

After years of dedicated efforts, CLARUS successfully completed the development of the first-generation amblyopia treatment device model in January 2010. Independently researched and developed by our team, this device overcame significant challenges in treating "eccentric fixation amblyopia." It demonstrates stable and effective treatment outcomes while addressing central amblyopia. The device is known for its user-friendly operation, safety in use, and a short treatment period, offering new hope for patients.

After the product's launch, it has continuously garnered recognition and endorsements from prominent figures in the field of ophthalmology both domestically and internationally. Simultaneously, it has brought new hope to patients.

The successful conclusion of this press conference raises our expectations that the amblyopia treatment device will bring light and hope to even more amblyopic patients.